Standard InChI: InChI=1S/C19H23N5O3/c1-22(2)9-4-10-23-15-7-8-16(24(25)26)19-17(15)18(21-23)13-11-12(27-3)5-6-14(13)20-19/h5-8,11,17,19-20H,4,9-10H2,1-3H3
1.Yang X, Wang ZP, Xiang S, Wang D, Zhao Y, Luo D, Qiu Y, Huang C, Guo J, Dai Y, Zhang SL, He Y.. (2022) Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer Activity., 65 (11.0):[PMID:35612499][10.1021/acs.jmedchem.2c00615]
2.Nehra B, Rulhania S, Jaswal S, Kumar B, Singh G, Monga V.. (2020) Recent advancements in the development of bioactive pyrazoline derivatives., 205 [PMID:32795767][10.1016/j.ejmech.2020.112666]
3.Uehling, D E DE and 9 more authors. 1995-03-31 Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs. [PMID:7707314]
4.Luzzio, M J MJ and 9 more authors. 1995-02-03 Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I. [PMID:7853331]
5.Wall, M E ME and 8 more authors. 1993-09-03 Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs. [PMID:8410981]
6.Lackey, K K and 10 more authors. 1996-02-02 Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin. [PMID:8576914]
7.Saulnier, Mark G MG and 23 more authors. 2005-04-07 Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11. [PMID:15801816]
8.Sunami, Satoshi S and 5 more authors. 2009-05-28 Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin. [PMID:19397324]